Quick Search
AMH and FSFI scores improved after recovery from COVID-19 pneumonia
Niyazi Tuğ1, Ceyhun Kılınç1, Pınar Eker2, Emre Yavuz1, Edip Emir1, Murat Yassa1, Pınar Birol1, Gaye Karagün Arslan11Department of Obstetrics and Gynecology, Şehit Prof. Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkey2Northern Clinics of İstanbul, Central Laboratory-2, İstanbul, Turkey
INTRODUCTION: The aim of this study was to investigate the effect of SARS-CoV-2 infection on female genitalia and sexual behavior.
METHODS: In this prospective cohort study in a COVID-19 pandemic clinic, women between 20 and 45 years of age with COVID-19 pneumonia but did not require intensive care were included. Serum anti-Müllerian hormone (AMH) measurements and female sexual function index (FSFI) scores were obtained during SARS-CoV-2 infection and 60–100 days after recovery.
RESULTS: Mean serum AMH concentrations at and after COVID-19 pneumonia were 2.29±1.84 and 2.92±2.46, respectively (p=0.017). FSFI scores after COVID-19 pneumonia were higher than those before the infection in all domains (p<0.05).
DISCUSSION AND CONCLUSION: SARS-CoV-2 infection seems to decrease AMH levels transiently in patients with pulmonary involvement, and recovery from the disease improves FSFI scores during the pandemics.
Corresponding Author: Niyazi Tuğ, Türkiye
Manuscript Language: English
